Humphrey Gardner, M.D., FCAP, joins Evelo as senior vice president, chief of medical oncology. Prior to joining Evelo, he was senior vice president of clinical development at Karyopharm. Dr. Gardner has also held the roles of associate director of discovery and translational research at Biogen, executive director of Oncology Translational Laboratories at Novartis, and VP of early development in both infection and in oncology at AstraZeneca. Earlier in his career, Dr. Gardner was an assistant professor at The Scripps Research Institute. Dr. Gardner trained in medicine at the University of Cambridge and in anatomic pathology at the Beth Israel Hospital, Boston. He also completed a postdoctoral fellowship at the Whitehead Institute.

Humphrey Gardner, M.D., FCAP, joins Evelo as senior vice president, chief of medical oncology. Prior to joining Evelo, he was senior vice president of clinical development at Karyopharm. Dr. Gardner has also held the roles of associate director of discovery and translational research at Biogen, executive director of Oncology Translational Laboratories at Novartis, and VP of early development in both infection and in oncology at AstraZeneca. Earlier in his career, Dr. Gardner was an assistant professor at The Scripps Research Institute. Dr. Gardner trained in medicine at the University of Cambridge and in anatomic pathology at the Beth Israel Hospital, Boston. He also completed a postdoctoral fellowship at the Whitehead Institute.